J0703 – Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg

Long description

Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg

Short description

Inj, cefepime hcl (b braun)

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

January 1, 2023

Last change

January 1, 2024 – No change

Nearby J codes

• J0694 – Injection, cefoxitin sodium, 1 gm
• J0695 – Injection, ceftolozane 50 mg and tazobactam 25 mg
• J0696 – Injection, ceftriaxone sodium, per 250 mg
• J0697 – Injection, sterile cefuroxime sodium, per 750 mg
• J0698 – Injection, cefotaxime sodium, per gm
• J0699 – Injection, cefiderocol, 10 mg
• J0701 – Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
• J0702 – Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
• J0706 – Injection, caffeine citrate, 5 mg
• J0710 – Injection, cephapirin sodium, up to 1 gm
• J0712 – Injection, ceftaroline fosamil, 10 mg
• J0713 – Injection, ceftazidime, per 500 mg
• J0714 – Injection, ceftazidime and avibactam, 0.5 g/0.125 g
• J0715 – Injection, ceftizoxime sodium, per 500 mg
• J0716 – Injection, centruroides immune f(ab)2, up to 120 milligrams
• J0717 – Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)